首页> 外文会议>Annual conference of the International Society of Exposure Science >Examining underlying assumptions when translating in vitro bioassay results to in vivo conditions
【24h】

Examining underlying assumptions when translating in vitro bioassay results to in vivo conditions

机译:在将体外生物测定结果转化为体内条件时检查基本假设

获取原文
获取外文期刊封面目录资料

摘要

In vitro testing is creating information that can be used to improve mechanistic understanding of toxicity pathways and for chemical assessments. The data can be used for hazard-based prioritization or they can be combined with exposure data for risk-based prioritization. Chemical potency comparisons require a consistent exposure metric ("x-axis") corresponding to the observed response ("y-axis"). Translating chemical concentrations from one system under specific conditions to a different system with different conditions requires consistent metrics and units. For example, the corroboration of in vitro data with in vivo data and comparisons of exposure and hazard concentrations for risk estimation require consideration of various sub-phase volumes and their sorptive capacities as well as chemical property information, e.g. partition coefficients. The freely dissolved concentration (Cfree; nmol/L) has been proposed as a relevant metric to translate concentrations across and within systems (e.g., blood-tissues). The objectives of this study were to examine commonly applied assumptions (e.g., Cblood, in vivo = Cnominal, in vitro) and alternative assumptions when translating in vitro bioassay results to in vivo conditions. Mass balance models and equilibrium partitioning theory were used to examine assumptions for translating in vitro test assay data to in vivo systems. A series of representative in vitro bioassay conditions are simulated with a suite of neutral hypothetical chemicals capturing a relevant range of partitioning properties (e.g. octanol-water partition coefficient, Kow). The first in vitro system (1) represents a cell-free assay. The second in vitro system (2) represents a cell-based test in which no serum is present during the test assay and the third in vitro system (3) represents a cell-based test in which 10% serum is present during the test assay. Differences in Cfree and Cblood / Cnom are relatively small for lower Kow chemicals (log Kow < 2) independent of the assay. However, as Kow increases, Cfree decreases. All else being equal, i.e., the magnitude of response in the assay for Cnom is the same for all chemicals, the higher Kow chemicals appear to be more potent than the lower Kow chemicals because they elicit the same response at lower Cfree. The difference in Cfree can be as much as 4-5 orders of magnitude lower. Extending the translation to Cblood and comparing against Cnom, the opposite interpretation would be made, i.e., the hydrophobic chemicals appear to be "less potent" because the concentration in blood required to elicit the same response in vitro (i.e., Cnom) is higher.
机译:体外测试正在创造可用于增进对毒性途径的机械理解和化学评估的信息。可以将数据用于基于危害的优先级,也可以将其与暴露数据结合以用于基于风险的优先级。化学效能比较需要与观察到的响应(“ y轴”)相对应的一致的暴露指标(“ x轴”)。将化学浓度从一个系统在特定条件下转换为具有不同条件的另一个系统,需要一致的度量单位。例如,体外数据与体内数据的确证以及用于风险估计的暴露和危害浓度的比较需要考虑各种亚相体积及其吸附能力以及化学性质信息,例如。分配系数。已经提出了自由溶解的浓度(Cfree; nmol / L)作为在系统(例如血液组织)之间和内部转化浓度的相关度量。这项研究的目的是在将体外生物测定结果转化为体内条件时,检查常用的假设(例如,Cblood,体内=名义,体外)和其他假设。质量平衡模型和平衡分配理论用于检验将体外测试分析数据转化为体内系统的假设。使用一系列捕获相关分配特性范围(例如辛醇-水分配系数,Kow)的中性假设化学物质模拟一系列代表性的体外生物测定条件。第一个体外系统(1)代表无细胞检测。第二体外系统(2)代表基于细胞的测试,其中在测试分析中不存在血清,而第三体外系统(3)代表基于细胞的测试,其中在测试分析中存在10%血清。对于较低的Kow化学品(log Kow <2),Cfree和Cblood / Cnom的差异相对较小,与测定方法无关。但是,随着Kow的增加,Cfree会减少。所有其他条件都相等,即,所有化学药品对Cnom的测定响应幅度均相同,较高的Kow化学药品似乎比较低的Kow化学药品更有效,因为它们在较低的Cfree下引起相同的响应。 Cfree的差异可能低4-5个数量级。将翻译扩展到Cblood并与Cnom进行比较,将得出相反的解释,即疏水化学物质似乎“效力较低”,因为在体外(即Cnom)引起相同反应所需的血液浓度更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号